+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Biopharmaceutical Process Analytical Technology Market by Product (Analyzers, Samples, Sensor & Probes), Mode (At-line Measurement, In-line Measurement, Off-line Measurement), Technology, Application, End-Users - Forecast 2024-2030

  • PDF Icon

    Report

  • 182 Pages
  • June 2024
  • Region: Global
  • 360iResearch™
  • ID: 5977764
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Biopharmaceutical Process Analytical Technology Market grew from USD 1.81 billion in 2023 to USD 2.05 billion in 2024. It is expected to continue growing at a CAGR of 14.45%, reaching USD 4.66 billion by 2030.

This proactive approach hinges on utilizing sensors, analyzers, and software systems that facilitate real-time data acquisition, allowing manufacturers to optimize processes and ensure products are both high-quality and consistent. Regulatory agencies such as the Food and Drug Administration (FDA) encourage the use of biopharmaceutical process analytical technology to improve process efficiency and product quality, leading to faster regulatory approvals. Increased demand for effective and high-quality biopharmaceutical products, such as vaccines and monoclonal antibodies, drives the adoption of biopharmaceutical process analytical technology. However, integrating new technologies, such as biopharmaceutical process analytical technology, with existing systems can be complex and time-consuming. Performance issues associated with biopharmaceutical process analytical technology, such as inaccuracies posed by sensors and data management complications, present challenges for the adoption of the technology. Innovations in sensors and analytics technology enable more precise, accurate, and real-time monitoring of production processes, promoting the adoption of biopharmaceutical process analytical technology. Using biopharmaceutical process analytical technology to make processes more efficient and less wasteful contributes to the broader goal of sustainable pharmaceutical manufacturing.

Regional Insights

In the Americas region, particularly in the U.S. and Canada, biopharmaceutical companies have been early adopters of biopharmaceutical process analytical technology, motivated by the Food and Drug Administration’s (FDA) encouragement to improve manufacturing efficiencies and ensure product quality. Investment in the technology is substantial, with numerous biopharmaceutical firms partnering with technology companies to innovate and scale up their biopharmaceutical process analytical technology solutions. Europe represents a significant landscape for biopharmaceutical process analytical technology, with robust healthcare systems and high consumer expectations for drug quality. The European Medicines Agency (EMA) emphasizes quality control in drug manufacturing, which enhances the demand for state-of-the-art biopharmaceutical process analytical technology systems. APAC nations have rapidly integrated biopharmaceutical process analytical technology in their biopharmaceutical sector, driven by government policies favoring innovation in drug manufacturing and a push towards international compliance standards. Biopharmaceutical process analytical technology is seen as essential for APAC companies to enhance competitiveness globally and meet the internal demand for reliable pharmaceuticals.

Market Insights

Market Dynamics

  • The market dynamics represent an ever-changing landscape of the Biopharmaceutical Process Analytical Technology Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

  • Increasing demand for biopharmaceuticals biologics
  • Regulatory bodies worldwide, endorse the use of PAT to ensure drug quality and manufacturing efficiency
  • Integration of PAT with modern technologies Artificial Intelligence (AI) and Machine Learning (ML) has enhanced its utility

Market Restraints

  • High implementation costs and limited standardization

Market Opportunities

  • Supportive regulatory frameworks and policies that streamline the approval process for biopharmaceutical products
  • Continuous investment in R&D is vital for the development of next-generation biopharmaceuticals and related technologies

Market Challenges

  • Complexities in Product Development and impact of counterfeit product

Market Segmentation Analysis

  • Product: Adoption of sensors and probes to ensure continuous monitoring and process optimization
  • End-Users: Expanding investments in biopharmaceutical companies across the world

Industry Insights

  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Biopharmaceutical Process Analytical Technology Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Biopharmaceutical Process Analytical Technology Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Launch of the Alliance iS Bio HPLC System, Enhancing Efficiency in Biopharma Quality Control

Waters Corporation has introduced the Alliance iS Bio HPLC System, a new high-performance liquid chromatography (HPLC) solution tailored for biopharmaceutical quality control (QC) laboratories. This advanced system integrates superior bio-separation technology and smart, instrument capabilities, aiming to cut down up to 40% of routine errors, thus reducing time spent on analyzing discrepancies in test results. This integration sets a new benchmark for lab performance by streamlining workflows and supporting compliance with increasingly stringent regulations.

Introduction of proteoCHIP EVO 96, Innovating Single Cell Proteomics with Enhanced Efficiency and Reproducibility

Cellenion introduced the proteoCHIP EVO 96, a cutting-edge tool designed for streamlined and high-throughput single cell proteomic analysis. Post-preparation, samples are efficiently transferred to Evotips through centrifugation, eliminating manual handling and significantly reducing the potential for error. The proteoCHIP EVO 96 sets a new standard for operational ease and reliability in single cell proteomics, promising more consistent and reproducible outcomes.

Introducing the Brevis GC-2050, A Compact, Versatile Gas Chromatography System

Shimadzu has unveiled the Brevis GC-2050, a groundbreaking Gas Chromatography system designed for maximum efficiency in minimal space. This system is particularly compact, with a width of just 350 mm, reducing its footprint by 35% compared to Shimadzu's previous models like the NexisGC-2030. The design supports future expansion, allowing seamless integration with additional modules such as headspace samplers and mass spectrometers, making the Brevis GC-2050 an ideal solution for various industries, aiming to optimize laboratory space without sacrificing analytical capabilities.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Biopharmaceutical Process Analytical Technology Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Biopharmaceutical Process Analytical Technology Market, highlighting leading vendors and their innovative profiles. These include ABB Ltd., Agilent Technologies, Inc., Anton Paar GmbH, Bio-Rad Laboratories, Bruker Corporation, Carl Zeiss AG, Danaher Corporation, Emerson Electric Co., F. Hoffmann-La Roche AG, GL Sciences Inc., Hamilton Company, Horiba, Ltd., Jasco, Inc., Merck KGaA, Mettler-Toledo International Inc., PerkinElmer, Inc., Sartorius AG, SCION Instruments NL BV, Shimadzu Corporation, Siemens Healthineers, Spectris PLC, SRI Instruments Europe GmbH, Teledyne Technologies, Thermo Fisher Scientific, Inc., and Waters Corporation.

Market Segmentation & Coverage

This research report categorizes the Biopharmaceutical Process Analytical Technology Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product

  • Analyzers
  • Samples
  • Sensor & Probes
  • Software

Mode

  • At-line Measurement
  • In-line Measurement
  • Off-line Measurement
  • On-line Measurement

Technology

  • Capillary Electrophoresis
  • Liquid Chromatography
  • Particle Size Analysis

Spectroscopy

  • Mass Spectroscopy
  • Ultraviolet Spectroscopy

Application

  • Drug Development & Manufacturing
  • Drug Discovery

End-Users

  • Academic & Research Institutions
  • Biopharmaceutical Companies
  • Contract Research Organizations (CROs)

Region

Americas

  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas

Asia-Pacific

  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam

Europe, Middle East & Africa

  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Purchase of this report includes 1 year online access with quarterly updates

Purchase of this report includes 1 year online access with quarterly updates

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing demand for biopharmaceuticals biologics
5.1.1.2. Regulatory bodies worldwide, endorse the use of PAT to ensure drug quality and manufacturing efficiency
5.1.1.3. Integration of PAT with modern technologies Artificial Intelligence (AI) and Machine Learning (ML) has enhanced its utility
5.1.2. Restraints
5.1.2.1. High implementation costs and limited standardization
5.1.3. Opportunities
5.1.3.1. Supportive regulatory frameworks and policies that streamline the approval process for biopharmaceutical products
5.1.3.2. Continuous investment in R&D is vital for the development of next-generation biopharmaceuticals and related technologies
5.1.4. Challenges
5.1.4.1. Complexities in Product Development and impact of counterfeit product
5.2. Market Segmentation Analysis
5.2.1. Product: Adoption of sensors and probes to ensure continuous monitoring and process optimization
5.2.2. End-Users: Expanding investments in biopharmaceutical companies across the world
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Biopharmaceutical Process Analytical Technology Market, by Product
6.1. Introduction
6.2. Analyzers
6.3. Samples
6.4. Sensor & Probes
6.5. Software
7. Biopharmaceutical Process Analytical Technology Market, by Mode
7.1. Introduction
7.2. At-line Measurement
7.3. In-line Measurement
7.4. Off-line Measurement
7.5. On-line Measurement
8. Biopharmaceutical Process Analytical Technology Market, by Technology
8.1. Introduction
8.2. Capillary Electrophoresis
8.3. Liquid Chromatography
8.4. Particle Size Analysis
8.5. Spectroscopy
9. Biopharmaceutical Process Analytical Technology Market, by Application
9.1. Introduction
9.2. Drug Development & Manufacturing
9.3. Drug Discovery
10. Biopharmaceutical Process Analytical Technology Market, by End-Users
10.1. Introduction
10.2. Academic & Research Institutions
10.3. Biopharmaceutical Companies
10.4. Contract Research Organizations (CROs)
11. Americas Biopharmaceutical Process Analytical Technology Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Biopharmaceutical Process Analytical Technology Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Biopharmaceutical Process Analytical Technology Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.3.1. Launch of the Alliance iS Bio HPLC System, Enhancing Efficiency in Biopharma Quality Control
14.3.2. Introduction of proteoCHIP EVO 96, Innovating Single Cell Proteomics with Enhanced Efficiency and Reproducibility
14.3.3. Introducing the Brevis GC-2050, A Compact, Versatile Gas Chromatography System
14.4. Strategy Analysis & Recommendation
15. Competitive Portfolio
15.1. Key Company Profiles
15.2. Key Product Portfolio
List of Figures
FIGURE 1. BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET RESEARCH PROCESS
FIGURE 2. BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET DYNAMICS
FIGURE 7. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY MODE, 2023 VS 2030 (%)
FIGURE 10. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY MODE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 12. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 14. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
FIGURE 16. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. AMERICAS BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 20. UNITED STATES BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 26. BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY ANALYZERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY ANALYZERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY SAMPLES, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY SAMPLES, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY SENSOR & PROBES, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY SENSOR & PROBES, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY SOFTWARE, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY AT-LINE MEASUREMENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY AT-LINE MEASUREMENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY IN-LINE MEASUREMENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY IN-LINE MEASUREMENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY OFF-LINE MEASUREMENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY OFF-LINE MEASUREMENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY ON-LINE MEASUREMENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY ON-LINE MEASUREMENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY CAPILLARY ELECTROPHORESIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY CAPILLARY ELECTROPHORESIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY LIQUID CHROMATOGRAPHY, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY LIQUID CHROMATOGRAPHY, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY PARTICLE SIZE ANALYSIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY PARTICLE SIZE ANALYSIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY SPECTROSCOPY, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY SPECTROSCOPY, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY SPECTROSCOPY, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY SPECTROSCOPY, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY MASS SPECTROSCOPY, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY MASS SPECTROSCOPY, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY ULTRAVIOLET SPECTROSCOPY, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY ULTRAVIOLET SPECTROSCOPY, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY DRUG DEVELOPMENT & MANUFACTURING, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY DRUG DEVELOPMENT & MANUFACTURING, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 51. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 52. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 53. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 54. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 55. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY REGION, 2018-2023 (USD MILLION)
TABLE 56. GLOBAL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY REGION, 2024-2030 (USD MILLION)
TABLE 57. AMERICAS BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 58. AMERICAS BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 59. AMERICAS BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
TABLE 60. AMERICAS BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
TABLE 61. AMERICAS BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 62. AMERICAS BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 63. AMERICAS BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY SPECTROSCOPY, 2018-2023 (USD MILLION)
TABLE 64. AMERICAS BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY SPECTROSCOPY, 2024-2030 (USD MILLION)
TABLE 65. AMERICAS BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 66. AMERICAS BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 67. AMERICAS BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 68. AMERICAS BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 69. AMERICAS BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 70. AMERICAS BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 71. ARGENTINA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 72. ARGENTINA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 73. ARGENTINA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
TABLE 74. ARGENTINA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
TABLE 75. ARGENTINA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 76. ARGENTINA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 77. ARGENTINA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY SPECTROSCOPY, 2018-2023 (USD MILLION)
TABLE 78. ARGENTINA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY SPECTROSCOPY, 2024-2030 (USD MILLION)
TABLE 79. ARGENTINA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 80. ARGENTINA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 81. ARGENTINA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 82. ARGENTINA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 83. BRAZIL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 84. BRAZIL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 85. BRAZIL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
TABLE 86. BRAZIL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
TABLE 87. BRAZIL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 88. BRAZIL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 89. BRAZIL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY SPECTROSCOPY, 2018-2023 (USD MILLION)
TABLE 90. BRAZIL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY SPECTROSCOPY, 2024-2030 (USD MILLION)
TABLE 91. BRAZIL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 92. BRAZIL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 93. BRAZIL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 94. BRAZIL BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 95. CANADA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 96. CANADA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 97. CANADA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
TABLE 98. CANADA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
TABLE 99. CANADA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 100. CANADA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 101. CANADA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY SPECTROSCOPY, 2018-2023 (USD MILLION)
TABLE 102. CANADA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY SPECTROSCOPY, 2024-2030 (USD MILLION)
TABLE 103. CANADA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 104. CANADA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 105. CANADA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 106. CANADA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 107. MEXICO BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 108. MEXICO BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 109. MEXICO BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
TABLE 110. MEXICO BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
TABLE 111. MEXICO BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 112. MEXICO BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 113. MEXICO BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY SPECTROSCOPY, 2018-2023 (USD MILLION)
TABLE 114. MEXICO BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY SPECTROSCOPY, 2024-2030 (USD MILLION)
TABLE 115. MEXICO BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 116. MEXICO BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 117. MEXICO BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 118. MEXICO BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 119. UNITED STATES BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 120. UNITED STATES BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 121. UNITED STATES BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
TABLE 122. UNITED STATES BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
TABLE 123. UNITED STATES BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 124. UNITED STATES BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 125. UNITED STATES BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY SPECTROSCOPY, 2018-2023 (USD MILLION)
TABLE 126. UNITED STATES BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY SPECTROSCOPY, 2024-2030 (USD MILLION)
TABLE 127. UNITED STATES BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 128. UNITED STATES BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 129. UNITED STATES BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 130. UNITED STATES BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 131. UNITED STATES BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 132. UNITED STATES BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 133. ASIA-PACIFIC BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 134. ASIA-PACIFIC BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 135. ASIA-PACIFIC BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
TABLE 136. ASIA-PACIFIC BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
TABLE 137. ASIA-PACIFIC BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 138. ASIA-PACIFIC BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 139. ASIA-PACIFIC BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY SPECTROSCOPY, 2018-2023 (USD MILLION)
TABLE 140. ASIA-PACIFIC BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY SPECTROSCOPY, 2024-2030 (USD MILLION)
TABLE 141. ASIA-PACIFIC BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 142. ASIA-PACIFIC BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 143. ASIA-PACIFIC BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 144. ASIA-PACIFIC BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 145. ASIA-PACIFIC BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 146. ASIA-PACIFIC BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 147. AUSTRALIA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 148. AUSTRALIA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 149. AUSTRALIA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
TABLE 150. AUSTRALIA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
TABLE 151. AUSTRALIA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 152. AUSTRALIA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 153. AUSTRALIA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY SPECTROSCOPY, 2018-2023 (USD MILLION)
TABLE 154. AUSTRALIA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY SPECTROSCOPY, 2024-2030 (USD MILLION)
TABLE 155. AUSTRALIA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 156. AUSTRALIA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 157. AUSTRALIA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 158. AUSTRALIA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 159. CHINA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 160. CHINA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 161. CHINA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
TABLE 162. CHINA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
TABLE 163. CHINA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 164. CHINA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 165. CHINA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY SPECTROSCOPY, 2018-2023 (USD MILLION)
TABLE 166. CHINA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY SPECTROSCOPY, 2024-2030 (USD MILLION)
TABLE 167. CHINA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 168. CHINA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 169. CHINA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 170. CHINA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 171. INDIA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 172. INDIA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 173. INDIA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
TABLE 174. INDIA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
TABLE 175. INDIA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 176. INDIA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 177. INDIA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY SPECTROSCOPY, 2018-2023 (USD MILLION)
TABLE 178. INDIA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY SPECTROSCOPY, 2024-2030 (USD MILLION)
TABLE 179. INDIA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 180. INDIA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 181. INDIA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 182. INDIA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 183. INDONESIA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 184. INDONESIA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 185. INDONESIA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
TABLE 186. INDONESIA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
TABLE 187. INDONESIA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 188. INDONESIA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 189. INDONESIA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY SPECTROSCOPY, 2018-2023 (USD MILLION)
TABLE 190. INDONESIA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY SPECTROSCOPY, 2024-2030 (USD MILLION)
TABLE 191. INDONESIA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 192. INDONESIA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 193. INDONESIA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 194. INDONESIA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 195. JAPAN BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 196. JAPAN BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 197. JAPAN BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
TABLE 198. JAPAN BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
TABLE 199. JAPAN BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 200. JAPAN BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 201. JAPAN BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY SPECTROSCOPY, 2018-2023 (USD MILLION)
TABLE 202. JAPAN BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY SPECTROSCOPY, 2024-2030 (USD MILLION)
TABLE 203. JAPAN BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 204. JAPAN BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 205. JAPAN BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 206. JAPAN BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 207. MALAYSIA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 208. MALAYSIA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 209. MALAYSIA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
TABLE 210. MALAYSIA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
TABLE 211. MALAYSIA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 212. MALAYSIA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 213. MALAYSIA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY SPECTROSCOPY, 2018-2023 (USD MILLION)
TABLE 214. MALAYSIA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY SPECTROSCOPY, 2024-2030 (USD MILLION)
TABLE 215. MALAYSIA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 216. MALAYSIA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 217. MALAYSIA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 218. MALAYSIA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 219. PHILIPPINES BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 220. PHILIPPINES BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 221. PHILIPPINES BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
TABLE 222. PHILIPPINES BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
TABLE 223. PHILIPPINES BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 224. PHILIPPINES BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 225. PHILIPPINES BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY SPECTROSCOPY, 2018-2023 (USD MILLION)
TABLE 226. PHILIPPINES BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY SPECTROSCOPY, 2024-2030 (USD MILLION)
TABLE 227. PHILIPPINES BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 228. PHILIPPINES BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 229. PHILIPPINES BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 230. PHILIPPINES BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 231. SINGAPORE BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 232. SINGAPORE BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 233. SINGAPORE BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
TABLE 234. SINGAPORE BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
TABLE 235. SINGAPORE BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 236. SINGAPORE BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 237. SINGAPORE BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY SPECTROSCOPY, 2018-2023 (USD MILLION)
TABLE 238. SINGAPORE BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY SPECTROSCOPY, 2024-2030 (USD MILLION)
TABLE 239. SINGAPORE BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 240. SINGAPORE BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 241. SINGAPORE BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 242. SINGAPORE BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 243. SOUTH KOREA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 244. SOUTH KOREA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 245. SOUTH KOREA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
TABLE 246. SOUTH KOREA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
TABLE 247. SOUTH KOREA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 248. SOUTH KOREA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 249. SOUTH KOREA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY SPECTROSCOPY, 2018-2023 (USD MILLION)
TABLE 250. SOUTH KOREA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY SPECTROSCOPY, 2024-2030 (USD MILLION)
TABLE 251. SOUTH KOREA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 252. SOUTH KOREA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 253. SOUTH KOREA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 254. SOUTH KOREA BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 255. TAIWAN BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 256. TAIWAN BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 257. TAIWAN BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
TABLE 258. TAIWAN BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
TABLE 259. TAIWAN BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 260. TAIWAN BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 261. TAIWAN BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY SPECTROSCOPY, 2018-2023 (USD MILLION)
TABLE 262. TAIWAN BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY SPECTROSCOPY, 2024-2030 (USD MILLION)
TABLE 263. TAIWAN BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 264. TAIWAN BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 265. TAIWAN BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 266. TAIWAN BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 267. THAILAND BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 268. THAILAND BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 269. THAILAND BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY MODE, 2018-2023 (USD MILLION)
TABLE 270. THAILAND BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY MODE, 2024-2030 (USD MILLION)
TABLE 271. THAILAND BIOPHARMACEUTICAL PROCESS ANALYTICAL TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 272. THAILAND BIOPHARMACEUTICAL PROC

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • ABB Ltd.
  • Agilent Technologies, Inc.
  • Anton Paar GmbH
  • Bio-Rad Laboratories
  • Bruker Corporation
  • Carl Zeiss AG
  • Danaher Corporation
  • Emerson Electric Co.
  • F. Hoffmann-La Roche AG
  • GL Sciences Inc.
  • Hamilton Company
  • Horiba, Ltd.
  • Jasco, Inc.
  • Merck KGaA
  • Mettler-Toledo International Inc.
  • PerkinElmer, Inc.
  • Sartorius AG
  • SCION Instruments NL BV
  • Shimadzu Corporation
  • Siemens Healthineers
  • Spectris PLC
  • SRI Instruments Europe GmbH
  • Teledyne Technologies
  • Thermo Fisher Scientific, Inc.
  • Waters Corporation

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages182
PublishedJune 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 2.05 Billion
Forecasted Market Value ( USD ) by 2030 $ 4.66 Billion
Compound Annual Growth Rate14.4%
Regions CoveredGlobal

Related Topics

Related Reports

Global Biopharmaceutical Process Analytical Technology Market Size by Technology (LC, GC, MS, qPCR, NGS, NMR, Raman, IR Spectroscopy), Product (Analyzer, Sensor, Software), Application (Vaccine, Biologics, CGT), and End User - Forecast to 2029 - Product Image

Global Biopharmaceutical Process Analytical Technology Market Size by Technology (LC, GC, MS, qPCR, NGS, NMR, Raman, IR Spectroscopy), Product (Analyzer, Sensor, Software), Application (Vaccine, Biologics, CGT), and End User - Forecast to 2029

  • Report
  • 248 Pages
  • Global
From
Global Process Analytical Technology Market by Products & Services (Products, Services), Measurement (At-Line Measurement, In-Line Measurement, Off-Line Measurement), Technique, End-User - Forecast 2024-2030 - Product Image

Global Process Analytical Technology Market by Products & Services (Products, Services), Measurement (At-Line Measurement, In-Line Measurement, Off-Line Measurement), Technique, End-User - Forecast 2024-2030

  • Report
  • 182 Pages
  • Global
From
Process Analytical Technology Market Size, Share & Trends Analysis Report By Product, By Technique, By Monitoring Method, By Application, By End Use, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Process Analytical Technology Market Size, Share & Trends Analysis Report By Product, By Technique, By Monitoring Method, By Application, By End Use, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 100 Pages
  • Global
From
Process Analytical Technology Market - Global Industry Size, Share, Trends, Opportunity & Forecast, 2019-2029F - Product Image

Process Analytical Technology Market - Global Industry Size, Share, Trends, Opportunity & Forecast, 2019-2029F

  • Report
  • 187 Pages
  • Global
From
Process Analytical Technology Global Market Report 2024 - Product Image

Process Analytical Technology Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.